For the first time, we investigated the pan-cancer analysis of eEF2K and eEF2, statistically correlating its expression was with pathological staging, clinical prognosis, and protein phosphorylation, which helps understand the role of eEF2K in tumorigenesis from the perspective of clinical tumor samples. This evidence concerns the gene EEF2K and cancer.